Consistent with this profibrotic function for NGAL, we found that LPS caused a marked increase in collagen 1 (a marker for liver fibrosis), whereas all three of our treatments reduced this LPS‐induced increment to normal. The gene discussed is LCN2; the disease is Hepatic fibrosis.